Aromatase Inhibitors

06/01/2007 - "Recently, the third-generation aromatase inhibitors (AIS) have demonstrated excellent efficacy in adjuvant breast cancer trials, and they show particular promise in the breast cancer prevention setting. "
01/01/2012 - "Aromatase inhibitors are very effective and safe in preventing recurrent disease in postmenopausal breast cancer. "
02/01/2008 - "Aromatase inhibitors for breast cancer: proven efficacy across the spectrum of disease."
07/01/1999 - "The high potency and selectivity of new aromatase inhibitors has translated to greater efficacy and improved tolerability in comparison with established second-line hormonal agents for advanced breast cancer in phase III clinical trials. "
01/01/2014 - "Major clinical trials and experimental studies showed that aromatase inhibitors are effective against postmenopausal breast cancer. "

01/01/2013 - "Aromatase inhibitors represent an innovative treatment for these rare and refractory tumors offering promising results while avoiding toxic and marginally active chemotherapeutic agents."
03/01/2006 - "In randomized clinical trials, each of the third-generation aromatase inhibitors (AIs) has demonstrated efficacy in the adjuvant treatment of postmenopausal women with receptor' -positive tumors. "
07/01/2014 - "The changes of VPR in the NCTx-treated group differed from those recorded for the patients treated with aromatase inhibitors and shown in our earlier study; this indicates that the reactions of the tumor-stromal interaction to therapy were different among different treatments in BC patients. "
06/01/2001 - "Recent clinical trials have demonstrated the efficacy and tolerability of the new generation of aromatase inhibitors as second-line and first-line therapy in postmenopausal women with breast cancers who were eligible for endocrine treatment. "
12/01/2015 - "In addition, it was demonstrated that metabolites can sensitize aromatase inhibitors-resistant cancer cells, by inducing apoptosis. "

08/01/2004 - "Recent studies have provided evidence that aromatase inhibitors may be effective in the short term for induction of ovulation and in the long-term for treatment of endometriosis. "
07/01/2011 - "Are aromatase inhibitors effective in endometriosis treatment?"
09/01/2003 - "The aromatase inhibitors may be also useful for the treatment of endometriosis and for ovulation induction as evidenced by preliminary data. "
12/01/2003 - "Few studies report efficacy of aromatase inhibitors in human endometriosis. "
05/01/2010 - "We conducted a systematic review of the literature and studied the efficacy of aromatase inhibitors on endometriosis. "

07/01/2014 - "Aromatase inhibitors show promise in the therapy of endometrial carcinoma, especially the early stage. "
07/01/2014 - "To review recent studies about the application of aromatase inhibitors in endometrial carcinoma and the benefits and challenges of aromatase inhibitors in this regard. "
04/01/2015 - "Aromatase inhibitors may reduce endometrial cancer risk."
07/01/2014 - "However, in advanced or recurrent endometrial carcinoma, the application of aromatase inhibitors cannot solve the problem evidently. "
07/01/2014 - "The therapeutic significance of aromatase inhibitors in endometrial carcinoma."

03/01/2006 - "The review summarizes the outcomes of several landmark trials involving aromatase inhibitors that helped formulate current therapeutic approaches recommended by the American Society of Clinical Oncology for breast carcinoma treatment."
07/04/2011 - "In ovarian carcinoma, several clinical studies recently demonstrated that aromatase inhibitors had some therapeutic activity against recurrent ovarian carcinoma. "
10/01/2005 - "New aromatase inhibitors as second-line endocrine therapy in postmenopausal patients with metastatic breast carcinoma: a pooled analysis of the randomized trials."
01/01/2015 - "Aromatase inhibitors (AIs) are anti-neoplastic drugs widely used for the treatment of endocrine responsive breast carcinoma in postmenopausal women. "
11/01/2010 - "Endometrioid ovarian carcinoma benefits from aromatase inhibitors: case report and literature review."